The effects of 5-fluorouracil on the proteome of colon cancer cells

Journal of Proteome Research

Volumn 12, Issue 4, 2013, Pages 1969-1979

  Marin Vicente, Consuelo ^a,b   Lyutvinskiy, Yaroslav ^b   Romans Fuertes, Patricia ^a,d   Zubarev, Roman A ^b,c   Visa, Neus ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SCIENCE FOR LIFE LABORATORY   (Sweden)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

mass spectrometry; proteomics; ribosomal proteins; RKO cells; translation

Indexed keywords

FLUOROURACIL; MESSENGER RNA; PROTEOME; RALTITREXED; RAPAMYCIN;

ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN METABOLISM; RECEPTOR DOWN REGULATION; RNA METABOLISM;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN BIOSYNTHESIS; PROTEOME; RIBOSOMAL PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84875958167     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400052p     Document Type: Article

References (35)

1. Longley, D. B.; McDermott, U.; Johnston, P. G. Predictive markers for colorectal cancer: current status and future prospects Clinical Colorectal Cancer 2003, 2 (4) 223-230
2. Wyatt, M. D.; Wilson, D. M., III. Participation of DNA repair in the response to 5-fluorouracil Cellular Mol. Life Sci. 2009, 66 (5) 788-799
3. Pettersen, H. S.; Visnes, T.; Vagbo, C. B.; Svaasand, E. K.; Doseth, B.; Slupphaug, G.; Kavli, B.; Krokan, H. E. UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation Nucleic Acids Res. 2011, 39 (19) 8430-8444
4. Doong, S. L.; Dolnick, B. J. 5-Fluorouracil substitution alters pre-mRNA splicing in vitro J. Biol. Chem. 1988, 263 (9) 4467-4473
5. Ghoshal, K.; Jacob, S. T. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil Cancer Res. 1994, 54 (3) 632-636
6. Hoskins, J.; Butler, J. S. RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p Genetics 2008, 179 (1) 323-330
7. Zhao, X.; Yu, Y. T. Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo Nucleic Acids Res. 2007, 35 (2) 550-558
8. Fang, F.; Hoskins, J.; Butler, J. S. 5-Fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs Mol. Cell. Biol. 2004, 24 (24) 10766-10776
9. Silverstein, R. A.; Gonzalez de Valdivia, E.; Visa, N. The incorporation of 5-fluorouracil into RNA affects the ribonucleolytic activity of the exosome subunit Rrp6 Mol. Cancer Res. 2011, 9 (3) 332-340
10. Scherf, U.; Ross, D. T.; Waltham, M.; Smith, L. H.; Lee, J. K.; Tanabe, L.; Kohn, K. W.; Reinhold, W. C.; Myers, T. G.; Andrews, D. T.; Scudiero, D. A.; Eisen, M. B.; Sausville, E. A.; Pommier, Y.; Botstein, D.; Brown, P. O.; Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer Nature Genet. 2000, 24 (3) 236-244
11. Lum, P. Y.; Armour, C. D.; Stepaniants, S. B.; Cavet, G.; Wolf, M. K.; Butler, J. S.; Hinshaw, J. C.; Garnier, P.; Prestwich, G. D.; Leonardson, A.; Garrett-Engele, P.; Rush, C. M.; Bard, M.; Schimmack, G.; Phillips, J. W.; Roberts, C. J.; Shoemaker, D. D. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes Cell 2004, 116 (1) 121-137
12. Schmid, M.; Jensen, T. H. The exosome: a multipurpose RNA-decay machine Trends Biochem. Sci. 2008, 33 (10) 501-510
13. Kammler, S.; Lykke-Andersen, S.; Jensen, T. H. The RNA exosome component hRrp6 is a target for 5-fluorouracil in human cells Mol. Cancer Res. 2008, 6 (6) 990-995
14. Zembutsu, H.; Ohnishi, Y.; Tsunoda, T.; Furukawa, Y.; Katagiri, T.; Ueyama, Y.; Tamaoki, N.; Nomura, T.; Kitahara, O.; Yanagawa, R.; Hirata, K.; Nakamura, Y. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs Cancer Res. 2002, 62 (2) 518-527
15. Maxwell, P. J.; Longley, D. B.; Latif, T.; Boyer, J.; Allen, W.; Lynch, M.; McDermott, U.; Harkin, D. P.; Allegra, C. J.; Johnston, P. G. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling Cancer Res. 2003, 63 (15) 4602-4606
16. Wong, C. S.; Wong, V. W.; Chan, C. M.; Ma, B. B.; Hui, E. P.; Wong, M. C.; Lam, M. Y.; Au, T. C.; Chan, W. H.; Cheuk, W.; Chan, A. T. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry Oncol. Rep. 2008, 20 (1) 89-98
17. Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Sigal, A.; Milo, R.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U. Dynamic proteomics of individual cancer cells in response to a drug Science 2008, 322 (5907) 1511-1516
18. Zubarev, R. A.; Nielsen, M. L.; Fung, E. M.; Savitski, M. M.; Kel-Margoulis, O.; Wingender, E.; Kel, A. Identification of dominant signaling pathways from proteomics expression data J. Proteomics 2008, 71 (1) 89-96
19. Good, D. M.; Zubarev, R. A. Drug target identification from protein dynamics using quantitative pathway analysis J. Proteome Res. 2011, 10 (5) 2679-2683
20. Celorio-Mancera, M. P.; Sundmalm, S. M.; Vogel, H.; Rutishauser, D.; Ytterberg, A. J.; Zubarev, R. A.; Janz, N. Chemosensory proteins, major salivary factors in caterpillar mandibular glands Insect Biochem. Mol. Biol. 2012, 10, 796-805
21. Eden, E.; Navon, R.; Steinfeld, I.; Lipson, D.; Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists BMC Bioinf. 2009, 10, 48
22. Jensen, L. J.; Kuhn, M.; Stark, M.; Chaffron, S.; Creevey, C.; Muller, J.; Doerks, T.; Julien, P.; Roth, A.; Simonovic, M.; Bork, P.; von Mering, C. STRING 8-a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Res. 2009, 37 (Database Issue) D412-D416
23. Amson, R.; Pece, S.; Lespagnol, A.; Vyas, R.; Mazzarol, G.; Tosoni, D.; Colaluca, I.; Viale, G.; Rodrigues-Ferreira, S.; Wynendaele, J.; Chaloin, O.; Hoebeke, J.; Marine, J. C.; Di Fiore, P. P.; Telerman, A. Reciprocal repression between P53 and TCTP Nature Med. 2012, 18 (1) 91-99
24. Napoli, I.; Mercaldo, V.; Boyl, P. P.; Eleuteri, B.; Zalfa, F.; De Rubeis, S.; Di Marino, D.; Mohr, E.; Massimi, M.; Falconi, M.; Witke, W.; Costa-Mattioli, M.; Sonenberg, N.; Achsel, T.; Bagni, C. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP Cell 2008, 134 (6) 1042-1054
25. Wang, L.; Li, H.; Zhang, Y.; Santella, R. M.; Weinstein, I. B. HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells Int. J. Cancer 2009, 124 (7) 1526-1534
26. Smallwood, A.; Hon, G. C.; Jin, F.; Henry, R. E.; Espinosa, J. M.; Ren, B. CBX3 regulates efficient RNA processing genome-wide Genome Res. 2012, 22 (8) 1426-1436
27. Magnuson, B.; Ekim, B.; Fingar, D. C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks Biochem. J. 2012, 441 (1) 1-21
28. Jang, C. Y.; Kim, H. D.; Kim, J. Ribosomal protein S3 interacts with TRADD to induce apoptosis through caspase dependent JNK activation Biochem. Biophys. Res. Commun. 2012, 421 (3) 474-478
29. Zoncu, R.; Efeyan, A.; Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing Nature Rev. Mol. Cell Biol. 2011, 12 (1) 21-35
30. Ajani, J. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers Cancer 2006, 107 (2) 221-231
31. Kudo, L. C.; Parfenova, L.; Vi, N.; Lau, K.; Pomakian, J.; Valdmanis, P.; Rouleau, G. A.; Vinters, H. V.; Wiedau-Pazos, M.; Karsten, S. L. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis Human Mol. Genet. 2010, 19 (16) 3233-3253
32. Wilkinson, D. S.; Pitot, H. C. Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine J. Biol. Chem. 1973, 248 (1) 63-68
33. Burger, K.; Muhl, B.; Harasim, T.; Rohrmoser, M.; Malamoussi, A.; Orban, M.; Kellner, M.; Gruber-Eber, A.; Kremmer, E.; Holzel, M.; Eick, D. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels J. Biol. Chem. 2010, 285 (16) 12416-12425
34. Lubas, M.; Christensen, M. S.; Kristiansen, M. S.; Domanski, M.; Falkenby, L. G.; Lykke-Andersen, S.; Andersen, J. S.; Dziembowski, A.; Jensen, T. H. Interaction profiling identifies the human nuclear exosome targeting complex Mol. Cell 2011, 43 (4) 624-637
35. Suzuki, A.; Kogo, R.; Kawahara, K.; Sasaki, M.; Nishio, M.; Maehama, T.; Sasaki, T.; Mimori, K.; Mori, M. A new PICTure of nucleolar stress Cancer Sci. 2012, 103 (4) 632-637